Showing results (91-100 of 281) with videos related to

Sort By:
Pageof 29
Scientific Reports|October 25, 2024
Model selection to achieve reproducible associations between resting state EEG features and autismWilliam E Carson, Samantha Major, Harshitha Akkineni, et al.
ACS Pharmacology & Translational Science|May 18, 2023
Fluorescent Detection of Peroxynitrite Produced by Myeloid-Derived Suppressor Cells in Cancer and Inhibition by DasatinibErick J Carlson, Himanshu Savardekar, Xiaojun Hu, et al.
Cancer Immunology, Immunotherapy : CII|January 26, 2005
Expression of STAT1 and STAT2 in malignant melanoma does not correlate with response to interferon-alpha adjuvant therapyGregory B Lesinski, Daniel Valentino, Erinn M Hade, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2010
Biobehavioral, immune, and health benefits following recurrence for psychological intervention participantsBarbara L Andersen, Lisa M Thornton, Charles L Shapiro, et al.
Oncoimmunology|October 25, 2019
Evidence for interaction of the NLRP3 inflammasome and Bruton's tyrosine kinase in tumor-associated macrophages: implications for myeloid cell production of interleukin-1betaBrooke Benner, Luke Scarberry, Andrew Stiff, et al.
World Journal of Surgical Oncology|February 13, 2007
Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgeryStephen P Povoski, Donn C Young, Michael J Walker, et al.
Drug Design, Development and Therapy|May 23, 2020
Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical DevelopmentBrooke Benner, Logan Good, Dionisia Quiroga, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteinsJason M Zimmerer, Gregory B Lesinski, Sri Vidya Kondadasula, et al.
Surgery|July 10, 2012
Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokinesEric Luedke, Alena Cristina Jaime-Ramirez, Neela Bhave, et al.
BMC Cancer|April 20, 2010
Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cellsGregory B Lesinski, Jason M Zimmerer, Melanie Kreiner, et al.
Pageof 29